1265 related articles for article (PubMed ID: 10867377)
1. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination with allergens in children].
Demoly P; Dhivert-Donnadieu H; Bousquet J
Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
[TBL] [Abstract][Full Text] [Related]
5. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
6. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
Esch RE; Bush RK; Peden D; Lockey RF
Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of injection-related and local immunotherapy].
Kuna P
Pol Merkur Lekarski; 2003 Jun; 14(84):695-9. PubMed ID: 14524308
[TBL] [Abstract][Full Text] [Related]
8. Advances in upper airway diseases and allergen immunotherapy.
Nelson HS
J Allergy Clin Immunol; 2006 May; 117(5):1047-53. PubMed ID: 16675331
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
10. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
12. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
14. Oral and sublingual immunotherapy: general aspects and critical considerations.
Passalacqua G; Venturi S; Zoccali P; Braido F; Ghiazza P; Mincarini M; Canonica GW
Wien Med Wochenschr; 1999; 149(14-15):433-7. PubMed ID: 10584288
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
16. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
17. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children.
Ibañez MD; Kaiser F; Knecht R; Armentia A; Schöpfer H; Tholstrup B; Bufe A
Pediatr Allergy Immunol; 2007 Sep; 18(6):516-22. PubMed ID: 17680910
[TBL] [Abstract][Full Text] [Related]
18. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
19. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
Mascarell L; Van Overtvelt L; Moingeon P
Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
[TBL] [Abstract][Full Text] [Related]
20. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
